Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease

Bone Marrow Transplantation, Published online: 09 December 2023; doi:10.1038/s41409-023-02165-3Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease

Source: Bone Marrow Transplantation - December 9, 2023 Category: Hematology Authors: Iskra Pusic Catherine Lee Muthu Veeraputhiran Chelsea Minor John F. DiPersio Source Type: research